ViewRay Incorporated

171 articles with ViewRay Incorporated

• ViewRay Announces Conference Call and Webcast of First Quarter 2019 Financial Results to be Held After Market on May 2, 2019

  4/11/2019

  ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first quarter 2019 financial results.

• ViewRay Announces Conference Call and Webcast of Fourth Quarter and Full Year 2018 Financial Results to be Held After Market on March 14, 2019

  2/14/2019

  ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its fourth quarter and full year 2018 financial results.

• World's First MRIdian Center Celebrates Five Years of MRI-Guided Radiation Treatments

  1/22/2019

  Siteman Cancer Center Advances Precision Cancer Care through Presentations, Peer-Reviewed Publications and Pioneering Clinical Experience on its MRIdian Systems

• ViewRay Announces Preliminary Fourth Quarter and Fiscal Year 2018 Results

  1/7/2019

  ViewRay, Inc. today announced preliminary results for the fourth quarter and full fiscal year ended December 31, 2018. The preliminary results have not been audited and are subject to change.

• ViewRay® to Present at the 37th Annual J.P. Morgan Healthcare Conference

  12/10/2018

  ViewRay, Inc. announced that the Company will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California. Scott Drake, President and CEO, is scheduled to present at 8:30 a.m. Pacific Time on Wednesday, January 9, 2019.

• Rob Fuchs joins ViewRay as Chief Human Resources Officer

  11/21/2018

  Mr. Fuchs has over 18 years of experience in leading human resources.

• ViewRay® to Present at 30th Annual Piper Jaffray Healthcare Conference

  11/14/2018

  ViewRay, Inc. (NASDAQ: VRAY) announced today that company management is scheduled to participate in a fireside chat at the 30th Annual Piper Jaffray Healthcare Conference in New York, NY.

• ViewRay Reports Third Quarter 2018 Results

  11/8/2018

  ViewRay, Inc. today announced financial results for the third quarter ended September 30, 2018.

• ViewRay signs agreement with GenesisCare to bring the first MRIdian MRI-guided radiotherapy systems to the UK

  10/29/2018

  New agreement expands access to precision radiotherapy for people with cancer

• Real-Time Adaptive Radiotherapy Capabilities of ViewRay's MRIdian Highlighted at Investor & Analyst Meeting at ASTRO 2018

  10/22/2018

  Leading Oncologists Provide Practical, Clinical, and Economic Rationale for MRIdian MRI-Guided Radiation Therapy in the Treatment of Cancer

• ViewRay Announces Conference Call and Webcast of Third Quarter 2018 Financial Results to be Held After Market on November 8, 2018

  10/18/2018

  ViewRay will hold a conference call on Thursday November 8, 2018 at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results.

• ASTRO 2018 Presentations to Feature Unique Capabilities and Clinical Outcomes of ViewRay's MRIdian Next Generation Cancer Care

  10/16/2018

  Presentations to Highlight Clinical Value of World's Only FDA-Cleared MRI-guided Radiotherapy System

• ViewRay® to Host Investor & Analyst Meeting at 2018 ASTRO Annual Meeting in San Antonio

  10/9/2018

  ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will hold a meeting for investors and analysts on Monday, October 22, 2018, during the annual meeting of the American Society for Radiation Oncology (ASTRO) in San Antonio, TX.

• ViewRay Appoints Industry Veteran James Alecxih as Chief Commercial Officer

  10/2/2018

  Mr. Alecxih to Lead Company's Commercial Expansion

• MRI-Guided Radiation Therapy Aims to Prolong Survival and Reduce Complications for the Most Challenging Cancers

  10/1/2018

  Leading Radiation Oncology Experts Convene to Discuss Future of Radiation Therapy

• ViewRay® to Present at the 2018 Cantor Global Healthcare Conference

  9/25/2018

  ViewRay, Inc. announced today that members of the executive management team are scheduled to present at the Cantor Global Healthcare Conference in New York, NY.

• ViewRay Announces Equity Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

  9/17/2018

  ViewRay, Inc. today announced grants of stock options and restricted stock units to several new officers and employees.

• ViewRay® to Participate in Upcoming Conferences

  8/31/2018

  ViewRay Incorporated (NASDAQ: VRAY) announced today that members of the executive management team are scheduled to participate in two upcoming investor conferences.

• ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of 18,648,649 shares of Its Common Stock

  8/17/2018

  ViewRay, Inc. announced the completion of its previously announced underwritten public offering of 18,648,649 shares of common stock at a price to the public of $9.25 per share

• ViewRay Announces Pricing of Public Offering of 16,216,217 Shares of Its Common Stock

  8/15/2018

  ViewRay, Inc. announced the pricing of an underwritten public offering of 16,216,217 shares of common stock at a price to the public of $9.25 per share